Tort · Mass Tort Glossary

GLP-1 / Ozempic Litigation

Also known as: Ozempic, Wegovy, Mounjaro

Mass tort litigation against manufacturers of GLP-1 receptor agonist drugs (semaglutide, tirzepatide) including Ozempic, Wegovy, and Mounjaro, alleging failure to warn about the risk of severe gastrointestinal conditions including gastroparesis. One of the largest active tort dockets by intake volume as of 2025–2026.

Related terms

FAERS (FDA Adverse Event Reporting System)Intake Criteria

Run this in a real campaign

Mass Tort Ad Agency manages claimant-acquisition campaigns built on the concepts in this glossary — transparent cost-plus-15% pricing, in-house CloudIntake qualification, and chain-of-custody on every signed retainer. See the torts we run or book a strategy call.

The language of mass tort advertising

This glossary is compiled by Mass Tort Ad Agency from 15 years and $250M+ in plaintiff Meta ad spend. Browse the full reference or talk to our team.

Browse the full glossary